Solazyme,
Inc. (NASDAQ: SZYM), a leading innovator in microalgae food
ingredients, announced today that they will be showcasing two
ingredients, Whole Algal Protein and Whole Algal Flour, at SupplySide
West (SSW) November 14th-15th in Las Vegas. The
breakthrough Whole Algal Protein is a vegan, all-natural source of good
quality protein that is highly digestible, while the Whole Algal Flour
is a multi-functional, lipid rich ingredient that can efficiently
replace fat sources or enhance mouth feel in a multitude of different
applications, including powder blends, bars and beverages. These
microalgae-derived, whole-food ingredients are also naturally rich in
fiber and micronutrients. Solazyme will be sampling Whole Algal Protein
and Whole Algal Flour applications at Booth 32086.
“We believe Solazyme’s Whole Algal Protein and Whole Algal Flour are
game-changing solutions for the nutrition industry because they operate
as whole-food ingredients, all while providing natural, clean label
benefits,” said Jean-Marc Rotsaert, Chief Operating Officer, Solazyme.
Whole Algal Protein and Whole Algal Flour are products in Solazyme’s
suite of microalgae food ingredients, which also includes a
revolutionary food oils portfolio.
To learn more about Solazyme’s innovative suite of microalgae
ingredients, please visit the sales team at SSW Booth 32086 or visit us
at www.solazyme.com.
About Solazyme, Inc.
Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils
and innovative microalgal food ingredients. Headquartered in South San
Francisco, Solazyme’s renewable products can replace or enhance oils
derived from the world's three existing sources — petroleum, plants and
animal fats.
Solazyme®, the Solazyme logo and other trademarks or service names are
trademarks of Solazyme, Inc.
Forward Looking Statements
This press release contains certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
about Solazyme, including statements that involve risks and
uncertainties concerning: Solazyme’s commercialization plans for
microalgae food ingredients and the performance and health benefits of
Solazyme’s microalgae food ingredients. When used in this press release,
the words “will”, “expects”, “intends” and other similar expressions and
any other statements that are not historical facts are intended to
identify those assertions as forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any
such statement may be influenced by a variety of factors, many of which
are beyond the control of Solazyme, that could cause actual outcomes and
results to be materially different from those projected, described,
expressed or implied in this press release due to a number of risks and
uncertainties. Potential risks and uncertainties include, among others:
Solazyme’s limited operating history; its limited history in
commercializing products; implementation risk in deploying new
technologies and products; and market acceptance of its products.
Accordingly, no assurances can be given that any of the events
anticipated by the forward-looking statements will transpire or occur,
or if any of them do so, what impact they will have on the results of
operations or financial condition of Solazyme. In addition, please refer
to the documents that Solazyme, Inc. files with the Securities and
Exchange Commission, including its Quarterly Reports on Form 10-Q, as
updated from time to time, for a discussion of these and other risks.
You are cautioned not to place undue reliance on forward-looking
statements, which speak only as of the date of this press
release. Solazyme is not under any duty to update any of the information
in this press release.
Copyright Business Wire 2013